BioTek Instruments Expands into Switzerland
News Jan 27, 2010
BioTek Switzerland was created from a previous partnership with Witec AG in Littau, Switzerland and will be managed by Margrit Limacher, Witec’s founder. Ms. Limacher will also continue management of the existing Witec AG with their focus on life science products at the same location.
“This new company is a logical result of Witec’s successful BioTek division business operations, and is expected to offer the same level of professional service and support for future growth,” noted Margrit Limacher. “Our customers will continue to have unrestricted and competent service and support when evaluating BioTek’s microplate instrumentation solutions.”
Briar Alpert, BioTek President and CEO added, “This enhanced business relationship will allow BioTek Switzerland to be well-connected to BioTek USA’s information systems with complete access to the company’s global scientific and application resources. Ultimately, this means enhanced customer satisfaction for our Swiss customers.”
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug CandidateNews
Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.READ MORE